Female genital warts

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 3, 2007, Pages 339-347

  Ghaemmaghami, Fatemeh ^a   Nazari, Zeinab ^a   Mehrda, Nili ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Condyloma acuminata; Genital warts; Human papilloma virus

Indexed keywords

CONDYLOMA ACUMINATUM; FEMALE; GYNECOLOGIC DISEASE; HUMAN; REVIEW; RISK FACTOR;

CONDYLOMATA ACUMINATA; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; RISK FACTORS;

EID: 44449084024     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (41)

1. Ali F, Abdel-Aziz A, Helmy MF, et al (1998). Prevalence of certain sexually transmitted viruses in Egypt. J Egypt Public Health Assoc, 73, 181-92
2. Ault KA (2006). Epidemiology and natural history of HPV infections in the female genital tract. Infect Dis Obstet Gynecol, Mar, 14, 40470
3. Baulon E, Vautravers A, Rodriquez B, et al (2007). Imiquimod and immune response modifiers in gynaecolog. Gynecol Obstet Fertil, 35, 149-57.
4. Brockmeyer NH, Poffhoff A, Bader A, et al (2006). Treatment of condylomata acuminata with pegylated interferon alfa- 2b in HIV-infected patients. Eur J Med Res, 11, 27-32
5. Brodell LA, Mercurio MG, Brodell RT (2007). The diagnosis and treatment of HPV-mediated genital lesions. Cutis, 79(4 Suppl), 5-10
6. Bryan JT (2007). Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine, 25(16), 3001-6
7. Carey FM, Quah SP, Dinsmore W, et al(2004). Patient assessment of anogenital warts and the success of treatment with home applied therapy. Int J STD AIDS,15, 316-8.
8. Carr J, Gyorfi T (2000). Human papillomavirus. Epidemiology, transmission and pathogenesis. Clin Lab Med, 20, 235-55
9. Claesson U, Lassus A, Happonen H, et al (1996). Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS, 7, 429-34
10. Cordellini M, Lagrutta A, Duranti F, et al. (1991). Cryosurgery in the treatment of condylomatosis. Minerva Chir,46, 609- 12
11. Cox JT (2003). Extensive condyloma acuminata treated with imiquimod 5 % cream: a case report. Clin Exp Dermatol, 28 (Suppl 1), 51-4
12. Doorbar J, Griffin H (2007). Intrabody strategies for the treatment of HPV-associated disease. Expert Opin Biol Ther, 7, 677-89
13. Ferenczy A, Behelak Y, Haber G, et al (1995). Treating vaginal and external anogenital condylomas with electrosurgery vs CO2 laser ablation. J Gynecol Surg, 11, 41-50
14. Gajewska M, Wielgos M, Kaminski P, et al (2006). The occurrence of genital types of human papillomavirus in normal pregnancy and in pregnant renal transplant recipients. Neuro Endocrinol Lett, 27, 529-34.
15. Gall SA (2001). Female genital warts: global trends and treatments. Infect Dis Obstet Gynecol, 9, 149- 54.
16. Ghaemmaghami F, Nazari Z (2007). Giant condyloma accuminatum mimicking vulvar verrucous carcinoma. Eur J Surg Oncol, 33, 668-9.
17. Gravitt PE, Jamshidi R (2005). Diagnosis and management of oncogenic cervical HPV infection. Infect Dis Clin North Am, 19, 439-58
18. Gross G (2001). Clinical aspects and therapy of anogenital warts and HPV-associated lesions. Hautarzt, 52, 6-17
19. Handsfield HH (1997). Clinical presentation and natural course of anogenital warts, Am J Med, 102, 16-20
20. Howett MK, Kuhl JP (2005). Microbicides for prevention of transmission of sexually transmitted diseases. Curr Pharm Des, 11(29), 3731-46
21. Kodner CM, Nasraty S (2004). Management of genital warts. Am Fam Physician, 70, 2335-42
22. Lacey C J N, Goodall R L, Ragnarson Tennvall G, et al (2003). al Group. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect, 79, 270-5
23. Lafuma A, Monsonego J, Moyal-Barracco M, et al (2003). A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France. Ann Dermatol Venereol, 130, 731-6
24. Madani TA (2006). Sexually transmitted infections in Saudi Arabia. BMC Infect Dis, 10, 3
25. Maw R (2004). Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS, 15, 357-64.
26. McClean H, Shann S (2005). A cross-sectional survey of treatment choices for anogenital warts. Int J STD AIDS, 16, 212-6
27. O'Mahony C (2005). Genital warts: Current and future management options. Am J Clin Dermatol, 6, 239-43
28. Ouerhani R, Juini H, Skhiri A, et al (2006). Condylomata acuminata during pregnancy; report of 15 cases. Tunis Med,84, 745-6
29. Padilla-Ailhaud A (2006). Carbon dioxide laser vaporization of condyloma acuminata. J Low Genit Tract Dis, 10, 238-41
30. Peate I (2006). Nursing care and treatment of the patient with HPV. Br J Nurs, 15, 1063-9
31. Pinto AP, Carvalho MC, Kolb S, et al (2007). Value of cytology in papillary condylomatous lesions of the cervix. Acta Cytol, 51, 51-60
32. Sadan O, Bilevsky E, Shejter E, et al (2005). Occurrence of CIN in generally healthy women with exophytic vulvar condyloma acuminata. Infect Dis Obstet gynecol,13,141-3
33. Scheinfeld N, Lehman DS (2006). An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J,12, 5.
34. Schneede P, Schlenker B, Hungerhuber E (2006). Condylomata acuminata: an indication for prophylactic HPV vaccination? Urologe A, 45, 1514-20.
35. Singh V, Sehgal A, Satyanarayana L, et al (1995). Clinical presentation of gynecologic infections among Indian women. Obstet Gynecol, 85, 215-9
36. Weyandt GH, Benoit S, Becker JC, et al. (2005). Controlled layered removal of anogenital warts by argon-plasma coagulation. J Dtsch Dermatol Ges, 3, 271-5
37. Wienecke R, Brockmeyer NH, Kreuter A (2006). HPV induced disease in HIV-positive patients. Hautarzt, 57, 994-8
38. Wiley DJ, Douglas J, Beutner K, et al (2002). External genital warts: diagnosis, treatment, and prevention.Clin Infect Dis, 35 (Suppl 2), S210-24
39. Wilson JD, Brown CB, Walker PP (2001). Factors involved in clearance of genital warts. Int J STD AIDS, 12,789-92
40. Yan J, Chen SL, Wang HN, et al (2006). Meta-analysis of 5% Imiquimod and 0.5% Podophyllotoxin in the treatment of Condylomata accuminata. Dermatology, 213,218-23
41. Zanotti KM, Belinson J (2002). Update on the diagnosis and treatment of HPV infection. Cleve Clin J Med, 69, 948, 951- 6 passim